Dr. Steven Kahn receives award from American Diabetes Association

The American Diabetes Association will present the Outstanding Achievement in Clinical Diabetes Research Award to Dr. Steven Kahn, director of the Diabetes Research Center at the University of Washington. This award recognizes outstanding contributions in patient-oriented, clinical outcomes research that have had a significant impact on diabetes prevention and treatment. Kahn will be recognized during the Association’s 76th Scientific Sessions. 
Steven Kahn
Dr. Steven Kahn is a UW professor of medicine.
Dr. Steven Kahn is a UW professor of medicine.

Kahn, who is a UW professor of medicine and a physician and researcher at VA Puget Sound Health Care System, is recognized for contributions to the understanding of normal metabolic physiology and the pathophysiology of type 2 diabetes. He described the link between insulin secretion and insulin sensitivity in humans, noting that healthy beta cells respond to insulin resistance by increasing insulin output. His work confirmed that this adaptive response is hindered in people with impaired glucose tolerance or type 2 diabetes, demonstrating that beta-cell dysfunction is central to the pathogenesis of type 2 diabetes.

Kahn went on to define the natural history of beta-cell dysfunction and its heritable basis. This understanding of diabetes pathophysiology has influenced the design and outcomes assessments of subsequent clinical trials.

The American Diabetes Association’s 76th Scientific Sessions will be held June 10-14, 2016, at the Ernest N. Morial Convention Center in New Orleans. 


Send us your ideas and suggestions.